Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (5) , 588-596
- https://doi.org/10.1038/modpathol.3800088
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Multitarget Fluorescence In Situ Hybridization Assay Detects Transitional Cell Carcinoma in the Majority of Patients with Bladder Cancer and Atypical or Negative Urine CytologyJournal of Urology, 2003
- Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagusGut, 2003
- A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimensCancer, 2002
- The Development of a Multitarget, Multicolor Fluorescence in Situ Hybridization Assay for the Detection of Urothelial Carcinoma in UrineThe Journal of Molecular Diagnostics, 2000
- Chromosomal Imbalances in Barrett's Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma SequenceThe American Journal of Pathology, 2000
- Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction RegionThe American Journal of Pathology, 1998
- Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytologyGastroenterology, 1997
- Mutations of p53 in barrett's esophagus and barrett's cancer: A prospective study of ninety-eight casesThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Detection of genetic changes in Barrett's adenocarcirioma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistryCytometry, 1994
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976